The Occurrence of the Freshwater Bryozoan Pottsiella Erecta (Potts) 1884 (Gymnolaemata: Paludicellidae) in Lake Erie

Author Institution: Great Lakes Fishery Laboratory, U.S. Bureau of Sport Fisheries and WildlifeThe collection of Pottsiella erecta in western Lake Erie in August 1972 represents the first reported occurrence of this species in the Great Lakes and a 110 km northward extension of its known range

The application of high-density genetic maps of rye for the detection of QTLs controlling morphological traits

The development of genetic maps is, nowadays, one of the most intensive research activities of plant geneticists. One of the major goals of genome mapping is the localisation of quantitative trait loci (QTLs). This study was aimed at the identification of QTLs controlling morphological traits of rye and comparison of their localisation on genetic maps constructed with the use of genetically different germplasms. For QTL analyses, two high-density consensus maps of two populations (RIL-S and RIL-M) of recombinant inbred lines (RIL) were applied. Plant height (Ph), length of spikes (Sl) and the number of spikelets per spike (Sps) were studied in both populations. Additionally, the number of kernels per spike under isolation (Kps), the weight of kernels per spike (Kw) and thousand kernel weight (Tkw) were assessed in the RIL-M population. Except for Tkw, the majority of the traits were correlated to each other. The non-parametric Kruskal–Wallis (K-W) test and composite interval mapping (CIM) revealed 18/48 and 24/18 regions of rye chromosomes engaged in the determination of Ph, Sl and Sps in the RIL-S and RIL-M populations, respectively. An additional 18/15 QTLs controlling Kps, Kw and Tkw were detected on a map of the RIL-M population. A numerous group of QTLs detected via CIM remained in agreement with the genomic regions found when the K-W test was applied. Frequently, the intervals indicated by CIM were narrower. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13353-013-0186-5) contains supplementary material, which is available to authorized users

Evaluation of pre-PCR processing approaches for enumeration of Salmonella enterica in naturally contaminated animal feed

Three pre-PCR processing strategies for the detection and/or quantification of Salmonella in naturally contaminated soy bean meal were evaluated

A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19

In December of 2019, an outbreak of a novel coronavirus flared in Wuhan, the capital city of the Hubei Province, China. The pathogen has been identified as a novel enveloped RNA beta-coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus SARS-CoV-2 is associated with a disease characterized by severe atypical pneumonia known as coronavirus 2019 (COVID-19). Typical symptoms of this disease include cough, fever, malaise, shortness of breath, gastrointestinal symptoms, anosmia, and, in severe cases, pneumonia.1 The high-risk group of COVID-19 patients includes people over the age of 60 years as well as people with existing cardiovascular disease and/or diabetes mellitus. Epidemiological investigations have suggested that the outbreak was associated with a live animal market in Wuhan. Within the first few months of the outbreak, cases were growing exponentially all over the world. The unabated spread of this deadly and highly infectious virus is a health emergency for all nations in the world and has led to the World Health Organization (WHO) declaring a pandemic on March 11, 2020. In this report, we consolidate and review the available clinically and preclinically relevant results emanating from in vitro animal models and clinical studies of drugs approved for emergency use as a treatment for COVID-19, including remdesivir, hydroxychloroquine, and lopinavir-ritonavir combinations. These compounds have been frequently touted as top candidates to treat COVID-19, but recent clinical reports suggest mixed outcomes on their efficacies within the current clinical protocol frameworks

Bioassays- Procedures and Results

Bioassay procedures to describe, evaluate, and predict potential hazard of toxic materials to organisms, ecosystems, and health-related aspects of polluted waters continue to receive widespread attention. However, synthesizing these diverse theoretical, methodological, and procedural entities into an integrated multidisciplinary approach to evaluate environ mental hazards of toxic substances remains difficult. Symposia proceedings pertinent to the toxic substances management in ecosystems have appeared1 and provide an overview of major problems and emerging solutions, including chapters on new bioassay protocols development, and multiple exposure toxicity paradigms. Conclusions and recommendations resulting from a toxicity testing workshop2 discussed current state-of-the-art, identified needed improvements in methodology and research priorities, and called for coordinated multidisciplinary activities regarding physico-chemical, photodegradation, biodegradation, accumulation, and ecotoxicology test protocols. A comprehensive review of test methods for ecotoxicology was prepared by the National Research Council,3 in conjunction with a companion document of working papers prepared for committee use.4 The report was critical of single-species tests to predict ecosystematic effects, and presented detailed discussions of chemical toxicity assessment, factors influencing chemical fate in terrestrial and aquatic ecosystems, relevant properties and processes, appropriate test systems and end points, and a detailed assessment strategy employing integrated use of test systems. Multispecies tests to address eco logical toxicity have been critically reviewed and evaluated,5 including methods for measuring chemical effects on aquatic and terrestrial population interactions and ecosystem properties. A primary conclusion is the need for development and standardization of tests for effects of chemicals on ecological parameters that are indicative of interspecific interactions, community dynamics, and ecosystem function

Development of Rapid Detection and Genetic Characterization of Salmonella in Poultry Breeder Feeds

Salmonella is a leading cause of foodborne illness in the United States, with poultry and poultry products being a primary source of infection to humans. Poultry may carry some Salmonella serovars without any signs or symptoms of disease and without causing any adverse effects to the health of the bird. Salmonella may be introduced to a flock by multiple environmental sources, but poultry feed is suspected to be a leading source. Detecting Salmonella in feed can be challenging because low levels of the bacteria may not be recovered using traditional culturing techniques. Numerous detection methodologies have been examined over the years for quantifying Salmonella in feeds and many have proven to be effective for Salmonella isolation and detection in a variety of feeds. However, given the potential need for increased detection sensitivity, molecular detection technologies may the best candidate for developing rapid sensitive methods for identifying small numbers of Salmonella in the background of large volumes of feed. Several studies have been done using polymerase chain reaction (PCR) assays and commercial kits to detect Salmonella spp. in a wide variety of feed sources. In addition, DNA array technology has recently been utilized to track the dissemination of a specific Salmonella serotype in feed mills. This review will discuss the processing of feeds and potential points in the process that may introduce Salmonella contamination to the feed. Detection methods currently used and the need for advances in these methods also will be discussed. Finally, implementation of rapid detection for optimizing control methods to prevent and remove any Salmonella contamination of feeds will be considered